Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies

doi:10.5500/wjt.v6.i4.689

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6014)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

348

WORD

302

HTML

3243

Figures (1-5)

128

Tables (1-3)

142

Sum=4163

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

760

Download

1091

Sum=1851

Dec 24, 2016 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Transplant. Dec 24, 2016; 6(4): 689-696
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.689

Open in New Tab Full Size Figure Download Figure

Figure 1 Incidence curves of antibody-mediated rejection at 1-year post-transplant. AMR: Antibody-mediated rejection; DSA: Donor-specific antibodies.

Open in New Tab Full Size Figure Download Figure

Figure 2 Graft function (estimated glomerular filtration rate at 1-year) post-transplantation according to donor-specific antibodies human leukocyte antigen loci. Boxes show the interquartile range of the values (median and percentile 25-75); whiskers show the lowest and the highest value within 1.5 times below or above the interquartile range, respectively. DSA: Donor-specific antibodies; eGFR: Estimated glomerular filtration rate.

Open in New Tab Full Size Figure Download Figure

Figure 3 Kidney graft survival curves according with donor-specific antibodies human leukocyte antigen loci. DSA: Donor-specific antibodies.

Open in New Tab Full Size Figure Download Figure

Figure 4 Graft function (estimated glomerular filtration rate at 1-year) post-transplantation according to antibody-mediated rejection occurrence. Boxes show the interquartile range of the values (median and percentile 25-75); whiskers show the lowest and the highest value within 1.5 times below or above the interquartile range, respectively. AMR: Antibody-mediated rejection; eGFR: Estimated glomerular filtration rate.

Open in New Tab Full Size Figure Download Figure

Figure 5 Kidney graft survival curves according with antibody-mediated rejection occurrence. AMR: Antibody-mediated rejection.

Citation: Santos S, Malheiro J, Tafulo S, Dias L, Carmo R, Sampaio S, Costa M, Campos A, Pedroso S, Almeida M, Martins LS, Henriques C, Cabrita A. Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies. World J Transplant 2016; 6(4): 689-696
URL: https://www.wjgnet.com/2220-3230/full/v6/i4/689.htm
DOI: https://dx.doi.org/10.5500/wjt.v6.i4.689